Back
Direxion Daily S&P Biotech Bear 3X Shares Vs. BlueLinx Holdings, Inc. Industry Stock Comparison
Sell
24
LABD
Direxion Daily S&P Biotech Bear 3X Shares
Last Price:
$20.84
Seasonality Move:
-0.37%
Buy
56
BXC
BlueLinx Holdings, Inc.
Last Price:
$62.78
Seasonality Move:
23.8%
Sell
24
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
is a Sell
Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $20.82. The Score for LABD is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
LABD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
BlueLinx Holdings, Inc. (BXC)
is a Buy
Is BlueLinx Holdings, Inc. a Buy, Sell or Hold?
-
The current BlueLinx Holdings, Inc. [BXC] share price is $62.77. The Score for BXC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LABD Stock Price Chart
What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bear 3X Shares share price today is $20.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABD is experiencing selling pressure, which indicates risk of future bearish movement.
BXC Stock Price Chart
What is BlueLinx Holdings, Inc.'s stock price today?
-
The BlueLinx Holdings, Inc. share price today is $62.77The current trend is relatively stagnant and BXC is experiencing slight selling pressure.
LABD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.69 | Sell |
| Relative Strength Index (14 RSI): | 36.36 | Sell |
| Chaikin Money Flow: | -2264299 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.77 - 24.95) | Sell |
| Bollinger Bands (100): | (24.74 - 53.9) | Sell |
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 50.34 | Buy |
| Chaikin Money Flow: | -17765 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.56 - 64.38) | Buy |
| Bollinger Bands (100): | (62.05 - 78.95) | Sell |
LABD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.55 | Sell |
| 20-day SMA: | 21.93 | Sell |
| 50-day SMA: | 26.81 | Sell |
| 200-day SMA: | 60.71 | Sell |
| 8-day EMA: | 21.68 | Sell |
| 20-day EMA: | 22.71 | Sell |
| 50-day EMA: | 28 | Sell |
| 200-day EMA: | 50.75 | Sell |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.3 | Sell |
| 20-day SMA: | 62.07 | Buy |
| 50-day SMA: | 63.8 | Sell |
| 200-day SMA: | 72.15 | Sell |
| 8-day EMA: | 63.44 | Sell |
| 20-day EMA: | 62.55 | Buy |
| 50-day EMA: | 64.39 | Sell |
| 200-day EMA: | 74.74 | Sell |
Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BlueLinx Holdings, Inc. Earnings Growth & BXC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.29 per share, and an increase next year of $0.86 per share.
Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BlueLinx Holdings, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||